期刊文献+

甲状腺乳头状癌组织CK19的表达及临床病理意义 被引量:6

下载PDF
导出
摘要 目的:观察甲状腺乳头状癌组织中细胞角蛋白19(CK19)的表达,探讨其在甲状腺乳头状癌发生发展中的作用。方法:用RT-PCR和免疫组织化学法检测甲状腺乳头状癌36例,良性甲状腺疾病19例及正常甲状腺组织8例中CK19基因mRNA和蛋白质的表达。结果:CK19基因mRNA和蛋白质表达一致,在甲状腺乳头状癌组与其他非癌组织间的表达差异均具有统计学意义(P<0.05);CK19基因mR-NA在有淋巴转移组的表达水平明显高于无淋巴转移组,差异也具有统计学意义(P<0.05)。结论:CK19基因在甲状腺乳头状癌中表达明显增加且与转移有关,提示CK19可能参与了甲状腺乳头状癌的发生发展过程,并与肿瘤的转移有关。
出处 《长江大学学报(自科版)(下旬)》 CAS 2009年第1期22-24,共3页 Journal of Yangtze University
基金 广西壮族自治区卫生厅科研课题(Z2005202)
  • 相关文献

参考文献5

二级参考文献45

  • 1杨清绪,邵春奎,冯智英,黄本强,韩安家,熊敏,赵文丽,武彤彤.CK19和甲状腺过氧化物酶表达在甲状腺疾病诊断中的作用[J].第一军医大学学报,2005,25(6):678-681. 被引量:12
  • 2赵延龙,陈江,姜汉国.Survivin、p53基因在甲状腺乳头状癌组织中表达的研究[J].哈尔滨医科大学学报,2006,40(1):23-26. 被引量:9
  • 3徐少明,王平,李祖栋.桥本氏病并发甲状腺癌[J].中华外科杂志,1996,34(7):424-426. 被引量:70
  • 4王晓红,刘雨飞,鲍宇浓,崔全才,王德田.甲状腺乳头状癌RET、CK19、TG、Ki-67的表达[J].临床与实验病理学杂志,2006,22(6):692-695. 被引量:14
  • 5Krismann M, Todt B, Schroder J, et al. low specificity of cytok eratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Onco1,1995,13(11) : 2769-2775.
  • 6Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non small-cell lung cancer without overt metastases. lancet,1996,347(9002) : 649-653.
  • 7Quinlan RA, John L, Frank WW, et al. Patterns of expression and organization of cytokeratin intermediate filaments. In: Edd W,Fischman D, Liem K (eds). Intermediate Filaments. New York:The New York Acad Sci, 1985,285-306.
  • 8Bader BL, Jahn L, Franke WW. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. E
  • 9Zhou QH, Gong YL, Qin Y, et al. Clinical significance of molecular diagnosis of micrometastasis in lymph nodes, peripheral blood and bone marrow in the treatment of patients with non-small cell lung cancer. Chin J Lung Cancer,2001,4(6) : 435-439. [周清华,
  • 10Gusterson B. Are micrometastases clinically relevant? Br J Hosp Med,1992,47(4): 247-248.

共引文献30

同被引文献63

  • 1武晓泓,陆晓婕,刘超,狄福松,何戎华,蒋须勤.甲状腺偶发结节的筛查及随访[J].中国实用内科杂志,2005,25(9):823-824. 被引量:30
  • 2冯景,张吉才,陶建蜀,吕军,付萍,郭建华,周有利.散发性乳腺癌患者血浆BRCA1基因启动子异常甲基化的检测[J].中国癌症杂志,2005,15(5):442-445. 被引量:14
  • 3钟来平,郑家伟,张志愿,张陈平,陈万涛,竺涵光.口腔鳞癌首诊患者血清Cyfra21-1检测的预后评价价值[J].中国口腔颌面外科杂志,2007,5(1):8-12. 被引量:21
  • 4Davies H,Bignell GR,Cox C,et al.Mutations of the BRAFgene in human cancer[J].Nature,2002,417(6892):949-954.
  • 5Jean Jacques Michels,Marnay Jacques,Michel Henry-Amar,et al.Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma[J].Human Pathology,2007,38(2):212-219.
  • 6Peter M.Sadow,Jennifer L.Hunt.Update on clinically important variants of papillary thyroid carcinoma[J].Diagnostic Histopathology,2011,17(3):106-113.
  • 7Andrew J.Gaudena,Stanislaw J.Gaudenb.Multiple cerebral metastases as a primary presentation in papillary thyroid carcinoma[J].Journal of Clinical Neuroscience,2010,17(3):379-380.
  • 8Shin E,Chung WY,Yang WI,et al.RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation[J].J Korean Med Sci,2005,20(1):98-104.
  • 9Sawangareetrakul P,Srisomsap C,Chokchaichamnankit D,et al.Galectin-3 expression in human papillary thyroid carcinoma[J].Cancer Genomics Proteomics,2008,5(2):117-22.
  • 10Dongbin Ahna,June Sik Parka,Jin Ho Sohn,et al.BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma[J].Auris Nasus Larynx,2011,7(11):1016.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部